E
Translational Development Acquisition Corp. TDAC
$10.17 -$0.01-0.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -8.00K -61.30K -800.00 -800.00 -483.80K
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- 482.30K
Total Other Non-Cash Items -122.30K 0.00 800.00 800.00 --
Change in Net Operating Assets -680.70K 20.80K 0.00 0.00 1.50K
Cash from Operations -811.00K -40.50K 0.00 0.00 0.00
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -174.23M -- -- -- --
Cash from Investing -174.23M -- -- -- --
Total Debt Issued 136.50K 200.00K 35.00K 35.00K --
Total Debt Repaid -800.00K -- -- -- --
Issuance of Common Stock 169.05M -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 6.86M -7.50K -- -- --
Cash from Financing 175.25M 192.50K 35.00K 35.00K --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- -200.00
Net Change in Cash 214.10K 152.00K 35.00K 35.00K -200.00